Ventas (NYSE:VTR) Price Target Raised to $93.00

Ventas (NYSE:VTRFree Report) had its target price boosted by Wells Fargo & Company from $88.00 to $93.00 in a report published on Thursday,Benzinga reports. The firm currently has an overweight rating on the real estate investment trust’s stock.

VTR has been the subject of a number of other reports. Argus set a $88.00 target price on shares of Ventas in a report on Tuesday, February 10th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Morgan Stanley set a $90.00 price target on Ventas in a report on Friday, February 13th. Scotiabank raised their price objective on Ventas from $80.00 to $93.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Finally, KeyCorp lifted their price objective on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $90.47.

Check Out Our Latest Research Report on Ventas

Ventas Price Performance

Shares of VTR opened at $82.00 on Thursday. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. Ventas has a fifty-two week low of $60.15 and a fifty-two week high of $88.36. The firm has a 50-day simple moving average of $83.04 and a 200-day simple moving average of $77.53. The company has a market capitalization of $38.95 billion, a price-to-earnings ratio of 151.86, a price-to-earnings-growth ratio of 2.02 and a beta of 0.73.

Ventas (NYSE:VTRGet Free Report) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business earned $0.81 earnings per share. The business’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities research analysts anticipate that Ventas will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is currently 385.19%.

Insider Activity

In other news, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the transaction, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. The trade was a 32.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 86,106 shares of company stock worth $6,931,397 over the last ninety days. 0.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of VTR. NewEdge Advisors LLC lifted its holdings in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after acquiring an additional 7,097 shares during the period. Empowered Funds LLC grew its holdings in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP increased its position in Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth increased its position in Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Cetera Investment Advisers raised its stake in Ventas by 3.4% during the second quarter. Cetera Investment Advisers now owns 36,918 shares of the real estate investment trust’s stock worth $2,331,000 after purchasing an additional 1,209 shares during the period. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Company Profile

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Read More

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.